Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor

Nature

Volumn 377, Issue 6551, 1995, Pages 748-750

  Ichiki, Toshihiro ^a   Labosky, Patricia A ^a   Shiota, Chiyo ^a   Okuyama, Shigeru ^b   Imagawa, Yasuko ^b   Fogo, Agnes ^a   Niimura, Fumio ^a   Ichikawa, Iekuni ^a   Hogan, Brigid L M ^a   Inagami, Tadashi ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY TEMPERATURE; BRAIN NUCLEUS; CENTRAL NERVOUS SYSTEM FUNCTION; CONTROLLED STUDY; DEPRESSOR RESPONSE; DEVELOPMENT; EXPLORATORY BEHAVIOR; FEMALE; FETUS; GENE EXPRESSION; GROWTH; HEMODYNAMICS; MALE; MITOGENESIS; MOUSE; NERVE FUNCTION; NONHUMAN; PHYSIOLOGY; PRESSOR RESPONSE; PRIORITY JOURNAL;

ANGIOTENSIN II; ANIMAL; BLOOD PRESSURE; BODY TEMPERATURE; CELL LINE; CROSSES, GENETIC; EXPLORATORY BEHAVIOR; FEMALE; GENE TARGETING; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; RECEPTORS, ANGIOTENSIN; VASOCONSTRICTOR AGENTS;

EID: 0028858478     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/377748a0     Document Type: Article

References (29)

1. Peach, M. J. Biochem. Pharmac. 30, 2745-2751 (1981).
2. Bottari, S. P., de Gasparo, M., Steckelings, U. M. & Levens, N. R. Front. Neuroendocr. 14, 123-171 (1993).
3. Timmermans, P. B. M. W. M., et al. Pharmac. Rev. 45, 205-251 (1993).
4. Sasaki, K., et al. Nature 351, 230-233 (1991).
5. Murphy, T. J., et al. Nature 351, 233-236 (1991).
6. Kambayashi, Y., et al. J. biol. Chem. 268, 24543-24546 (1993).
7. Mukoyama, M., et al. J. biol. Chem. 268, 24539-24542 (1993).
8. Sumners, C., et al. Proc. natn. Acad. Sci. U.S.A. 88, 7567-7571 (1991).
9. Buisson, B., et al. J. biol. Chem. 270, 1670-1674 (1995).
10. Stoll, M., et al. J. clin. Invest. 95, 651-657 (1995).
11. Lo, M., et al. J. clin. Invest. 95, 1394-1397 (1995).
12. Grady, E. F., et al. J. clin. Invest. 88, 921-933 (1991).
13. Tsutsumi, K. & Saavedra, J. M. Am. J. Physiol. 261, R209-R216 (1991).
14. Ichiki, T. & Inagami, T. Circ. Res. 76, 693-700 (1995).
15. Kuhn, R., Rajewsky, K. & Muller, W. Science 254, 707-710 (1991).
16. Koike, G., et al. Biochem. biophys. Res. Commun. 203, 1842-1850 (1994).
17. Irwin, S. in Drug Screening and Evaluation of New Compounds in Animals (ed. Nodine, J. H. & Siegler, D. E.) 36-54 (Year Book Medical, Chicago, 1964).
18. Ichihara, K., Nabeshima, T. & Kameyama, T. J. Pharmac. Exp. Ther 264, 122-128 (1993).
19. Tanimoto, K., et al. J. biol. Chem. 269, 31334-31337 (1994).
20. Smithies, O. & Kim, H. S. Proc. natn. Acad. Sci. U.S.A. 91, 3612-3615 (1994).
21. Tofovic, S. P., Pong, A. S. & Jackson, E. K. Hypertension 18, 774-782 (1991).
22. Keiser, J. A., et al. J. Pharmac. Exp. Ther. 262, 1154-1160 (1992).
23. Naver, L., Stromberg, C. & Saavedra, J. M. Reg. Peptide 52, 21-29 (1994).
24. Scheuer, D. A. & Perrone, M. H. Am. J. Physiol. 264, R917-R923 (1993).
25. Yoshida, M., Hamakubo, T. & Inagami, T. Am. J. Physiol. 266, R802-R808 (1994).
26. Hein, L., Barsh, G. S., Richard, R. E., Dzau, V. J. & Kobilka, B. K., et al. Nature 377, 744-748 (1995).
27. Phillips, M. l., Speakman, E. A. & Kimura, B. Reg. Peptides 43, 1-20 (1993).
28. Ashton, H. in Brain Systems, Disorders, and Psychotropic Drugs (ed. Ashton, H.) 1-49 (Oxford University Press, 1987).
29. Solis-Ramires, R., et al. in Guide to Techniques in Mouse Development (eds Wassarman, P. M. & DePamphilis, M. L.) 855-878 (Academic, San Diego, 1993).